Comment on Xie et al.: The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

Ditte Bjerre; Laura Ferrero; Majbritt Madsen; Peter R Hansen; Henrik B Rasmussen; INDICES Consortium; Kerstin J Plessen; Pia Jeppesen; Tine Houmann; Kristine Kaalund-Brok; Anne Katrine Pagsberg

doi:10.1097/FPC.0000000000000114

Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

Ditte Bjerre, Laura Ferrero, Majbritt Madsen, Peter R Hansen, Henrik B Rasmussen, INDICES Consortium, Kerstin J Plessen (Member of author group), Pia Jeppesen (Member of author group), Tine Houmann (Member of author group), Kristine Kaalund-Brok (Member of author group), Anne Katrine Pagsberg (Member of author group)

2 Citations (Scopus)

Original language	English
Journal	Pharmacogenetics and Genomics
Volume	25
Issue number	3
Pages (from-to)	147
ISSN	1744-6872
DOIs	https://doi.org/10.1097/FPC.0000000000000114
Publication status	Published - Mar 2015

Access to Document

10.1097/FPC.0000000000000114

Cite this

Bjerre, D., Ferrero, L., Madsen, M., Hansen, P. R., Rasmussen, H. B., INDICES Consortium, Plessen , K. J., Jeppesen, P., Houmann, T., Kaalund-Brok, K., & Pagsberg, A. K. (2015). Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. Pharmacogenetics and Genomics, 25(3), 147. https://doi.org/10.1097/FPC.0000000000000114

Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. / Bjerre, Ditte; Ferrero, Laura; Madsen, Majbritt et al.
In: Pharmacogenetics and Genomics, Vol. 25, No. 3, 03.2015, p. 147.

Research output: Contribution to journal › Comment/debate › Research › peer-review

Bjerre, D, Ferrero, L, Madsen, M , Hansen, PR , Rasmussen, HB, INDICES Consortium, Plessen , KJ, Jeppesen, P, Houmann, T, Kaalund-Brok, K & Pagsberg, AK 2015, 'Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease', Pharmacogenetics and Genomics, vol. 25, no. 3, pp. 147. https://doi.org/10.1097/FPC.0000000000000114

@article{778af5f891604f37bb0aa60c28b0822c,

title = "Comment on Xie et al.: The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease",

author = "Ditte Bjerre and Laura Ferrero and Majbritt Madsen and Hansen, \{Peter R\} and Rasmussen, \{Henrik B\} and \{INDICES Consortium\} and Plessen, \{Kerstin J\} and Pia Jeppesen and Tine Houmann and Kristine Kaalund-Brok and Pagsberg, \{Anne Katrine\}",

year = "2015",

month = mar,

doi = "10.1097/FPC.0000000000000114",

language = "English",

volume = "25",

pages = "147",

journal = "Pharmacogenetics and Genomics",

issn = "1744-6872",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Comment on Xie et al.

T2 - The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

AU - Bjerre, Ditte

AU - Ferrero, Laura

AU - Madsen, Majbritt

AU - Hansen, Peter R

AU - Rasmussen, Henrik B

AU - INDICES Consortium

A2 - Plessen , Kerstin J

A2 - Jeppesen, Pia

A2 - Houmann, Tine

A2 - Kaalund-Brok, Kristine

A2 - Pagsberg, Anne Katrine

PY - 2015/3

Y1 - 2015/3

UR - https://www.scopus.com/pages/publications/84923188366

U2 - 10.1097/FPC.0000000000000114

DO - 10.1097/FPC.0000000000000114

M3 - Comment/debate

C2 - 25647335

SN - 1744-6872

VL - 25

SP - 147

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

IS - 3

ER -

Comment on Xie et al. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease

Access to Document

Other files and links

Cite this